Quarterly results for Epigral Ltd

Epigral Limited (Formerly Meghmani Finechem Limited) – Q1 FY26 Results Summary
Announcement Date: August 2, 2025

• Revenue: ₹606.54 crore, down 6.9% YoY and 3.4% QoQ.
• Profit After Tax (PAT): ₹160.41 crore, up ~87% YoY and QoQ, driven by a one-time deferred tax credit of ₹80.87 crore following adoption of reduced corporate tax rate under Section 115BAA.
• Earnings Per Share (Basic): ₹37.18, up from ₹20.70 in Q1 FY25 and ₹20.08 in Q4 FY25.
• EBITDA Proxy: Operating profitability remains stable; finance costs increased to ₹23.37 crore from ₹11.77 crore QoQ.
• Power and Fuel Expenses: Increased YoY, reflecting higher power procurement costs.

Balance Sheet / Investments:
- Invested ₹0.13 crore equity and ₹21.25 crore in optionally convertible debentures in Prozeal Green Power Private Limited, developing a 19.80 MW Wind Solar Hybrid Power Plant in Gujarat.
- Entered a 20-year Energy Supply Agreement to purchase minimum 51% of power generated by the associate.
- Board approved raising up to ₹400 crore via debt instruments for growth or refinancing.

Management Commentary:
- Adoption of Section 115BAA resulted in a one-time deferred tax credit boosting PAT.
- Strategic diversification into renewable energy with long-term power purchase agreement.
- No changes in business segments; operations remain focused on Chloro Alkali & derivatives with domestic sales.

Auditor’s Note:
- Clean limited review report with no qualifications or concerns.

Outlook:
- No explicit guidance provided; key focus areas include monitoring the impact of tax changes, deployment of raised funds, and managing rising finance and power costs.

Note: This is an AI generated summary of the results. There may be inaccuracies in the summary. Please refer to the original document before making investment decisions.